Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Sarepta Therapeutics, Inc. (SRPT) had Income from Continuous Operations of $196.89M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$611.09M |
|
$196.89M |
|
$152.56M |
|
$458.53M |
|
$495.51M |
|
$115.58M |
|
$38.06M |
|
$153.64M |
|
$153.64M |
|
$196.89M |
|
|
Income from Continuous Operations |
$196.89M |
$196.89M |
|
$196.89M |
|
$115.58M |
|
$124.55M |
|
98.00M |
|
106.62M |
|
$2.01 |
|
$1.89 |
|
| Balance Sheet Financials | |
$2.66B |
|
$371.86M |
|
$1.02B |
|
$3.68B |
|
$919.95M |
|
$1.14B |
|
$1.40B |
|
$2.32B |
|
$1.36B |
|
$1.36B |
|
$1.36B |
|
97.71M |
|
| Cash Flow Statement Financials | |
$-322.10M |
|
$-258.97M |
|
$-11.35M |
|
$1.12B |
|
$526.18M |
|
$-592.41M |
|
$78.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.89 |
|
-- |
|
-- |
|
0.46 |
|
0.84 |
|
75.04% |
|
18.91% |
|
18.91% |
|
-- |
|
25.14% |
|
32.22% |
|
$-397.55M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.15 |
|
1.16 |
|
77.66 |
|
14.51% |
|
14.51% |
|
5.35% |
|
7.89% |
|
$13.89 |
|
$-3.73 |
|
$-3.02 |
|